Therapeutics & Vaccines
Treatment of Solid Tumors With a Regimen of Targeted Radionuclide Therapy and Genetically Engineered Immune Cell Therapies
WARF: P240021US02
Inventors: Zachary Morris, Quaovi Sodji, Christian Capitini
The Invention
UW-Madison researchers have developed a combination of low dose radiation with a CAR T cell to treat solid tumors. They provided a low dose of targeted radionuclide therapy given prior to CAR T cell infusion. The dose and timing of this is critical. The dosing of the targeted radionuclide therapy in particular is very low, a dose that has never been employed clinically for therapeutic benefit.
Additional Information
For More Information About the Inventors
Tech Fields
For current licensing status, please contact Rafael Diaz at [javascript protected email address] or 608-960-9847